Guardant Health Inc (NAS:GH)
$ 29.54 0 (0%) Market Cap: 3.61 Bil Enterprise Value: 3.83 Bil PE Ratio: 0 PB Ratio: 52.66 GF Score: 70/100

Guardant Health Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 12, 2022 / 12:10PM GMT
Release Date Price: $61 (+2.90%)
Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst

Thanks for joining us this morning. My name is Tejas Savant, and I'm the life science tools and diagnostics analyst here at Morgan Stanley. It's my pleasure to host Guardant Health here. We have Helmy, AmirAli and Mike from the company.

Maybe before we kick things off, I just have a disclaimer I need to read off. It's: for important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales rep. So with that, Helmy, thank you for joining us.

Questions & Answers

Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst

Maybe just to kick things off, if both you and AmirAli can highlight what you view as key accomplishments for Guardant over the course of the last year? And what are you most looking forward to over the next 12 to 18 months?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot